Page 10 - Pnt O News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pnt o. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pnt O Today - Breaking & Trending Today

POINT Biopharma Global (NASDAQ:PNT) Shares Down 4.6%

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report)’s share price dropped 4.6% during mid-day trading on Tuesday . The stock traded as low as $9.25 and last traded at $9.26. Approximately 554,685 shares traded hands during trading, a decline of 15% from the average daily volume of 654,392 shares. The stock had previously closed […] ....

Raymond James , Piper Sandler , Balyasny Asset Management , Pier Capital , Biopharma Global Inc , Point Biopharma Global Inc , Vanguard Group Inc , Get Free Report , Global Price , Street Corp , Asset Management , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Stock Price Down 5.5%

POINT Biopharma Global Inc. (NASDAQ:PNT – Get Rating)’s stock price fell 5.5% during trading on Monday . The stock traded as low as $9.51 and last traded at $9.56. 395,471 shares changed hands during trading, a decline of 40% from the average session volume of 659,134 shares. The stock had previously closed at $10.12. Analysts […] ....

Raymond James , Piper Sandler , Capital Management , Proshare Advisors , Principal Financial Group Inc , Tudor Investment Corp Et Al , Biopharma Global Inc , Point Biopharma Global Inc , Get Rating , Global Stock , Share Advisors , Principal Financial Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

Brokerages Set POINT Biopharma Global Inc. (NASDAQ:PNT) Price Target at $16.00

Shares of POINT Biopharma Global Inc. (NASDAQ:PNT – Get Rating) have been given an average rating of “Buy” by the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have issued a report […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Raymond James , Capital Management , Psagot Value Holdings Ltd , Biopharma Global Inc , Principal Financial Group Inc , Biopharma Global Company Profile , Get Rating , Marketbeat Ratings , Value Holdings , Kantonalbank Zurich Cantonalbank , Financial Group , Global Company , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt ,

POINT Biopharma Global (NASDAQ:PNT) Price Target Increased to $13.00 by Analysts at Raymond James

POINT Biopharma Global (NASDAQ:PNT – Get Rating) had its price target upped by Raymond James from $11.00 to $13.00 in a research note released on Thursday, BayStreet.CA reports. The firm currently has an outperform rating on the stock. Raymond James also issued estimates for POINT Biopharma Global’s FY2023 earnings at $1.40 EPS, Q2 2024 earnings […] ....

Zurcher Kantonalbank Zurich Cantonalbank , Raymond James , Psagot Value Holdings Ltd , Principal Financial Group Inc , Capital Management , Biopharma Global Inc , Get Rating , Value Holdings , Kantonalbank Zurich Cantonalbank , Financial Group , Global Inc , Global Daily , Point Biopharma Global , Nasdaq Pnt , Boost Price Target ,